Resistell

The fastest and most extensible Antibiotic Susceptibility Testing (AST) Platform

Basel, Switzerland · Founded 2018 · $13.1M raised

Headquarters
Basel
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$13.1M
Last Round
$9.2M Series BDec 2022
Rounds
2

About

Resistell is a Swiss medtech company based in Basel that has commercialized a nanomotion-based rapid antibiotic susceptibility testing (AST) device, technology invented at EPFL's Laboratory of Physics of Living Matter. Founded in 2018 as a spin-off from the École Polytechnique Fédérale de Lausanne, Resistell's diagnostic platform helps clinicians identify effective antibiotics for bacterial infections such as sepsis faster than traditional culture-based methods, addressing the growing threat of antimicrobial resistance (AMR).

Summary

Resistell is a Biotech company based in Basel, Switzerland, founded in 2018. It has raised $13.1M in total across 2 rounds, most recently a $9.2M Series B round in Dec 2022. Investors include OCCIDENT, European Innovation Council Fund and TRUMPF Venture.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BDec 2022
$9.2M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Resistell on Indexed.vc
<a href="https://indexed.vc/companies/resistell"><img src="https://indexed.vc/api/badge/company/resistell" alt="Resistell on Indexed.vc" width="260" height="76" /></a>